Physician Publications

M. Adham Salkeni, MD, FRCPC

June 15, 2022

Abstract CT115: Safety and efficacy of Anti-PD-L1 antibody MEDI4736 (durvalumab) in combination with capecitabine in patients with advanced solid tumors (DURVA+)

Read More

Chao Yin, MD

June 8, 2022

Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Read More

Alexander I Spira MD, PhD, FACP, FASCO

June 3, 2022

KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients

Read More

Alexander I Spira MD, PhD, FACP, FASCO

June 3, 2022

Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C Mutation

Read More

Alexander I Spira MD, PhD, FACP, FASCO

June 3, 2022

Adagrasib Induces Promising Efficacy, Deep Responses in KRAS G12C NSCLC

Read More

Alexander I Spira MD, PhD, FACP, FASCO

June 3, 2022

ASCO 2022 | KRYSTAL-1: activity and safety of adagrasib in patients with advanced/metastatic KRASG12Cm NSCLC

Read More